FR2456744B1 - - Google Patents

Info

Publication number
FR2456744B1
FR2456744B1 FR8010562A FR8010562A FR2456744B1 FR 2456744 B1 FR2456744 B1 FR 2456744B1 FR 8010562 A FR8010562 A FR 8010562A FR 8010562 A FR8010562 A FR 8010562A FR 2456744 B1 FR2456744 B1 FR 2456744B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8010562A
Other languages
French (fr)
Other versions
FR2456744A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FR2456744A1 publication Critical patent/FR2456744A1/fr
Application granted granted Critical
Publication of FR2456744B1 publication Critical patent/FR2456744B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8010562A 1979-05-18 1980-05-12 Derives de la pyrazolo (1,5-c)quinazoline, procede de preparation de ces derives et medicaments contenant ces derniers Granted FR2456744A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79EE2663A HU178523B (en) 1979-05-18 1979-05-18 Process for preparing new pyrazolo-quinazoline derivatives

Publications (2)

Publication Number Publication Date
FR2456744A1 FR2456744A1 (fr) 1980-12-12
FR2456744B1 true FR2456744B1 (Direct) 1983-06-17

Family

ID=10995850

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8010562A Granted FR2456744A1 (fr) 1979-05-18 1980-05-12 Derives de la pyrazolo (1,5-c)quinazoline, procede de preparation de ces derives et medicaments contenant ces derniers

Country Status (17)

Country Link
US (1) US4303660A (Direct)
JP (1) JPS55154974A (Direct)
AT (1) AT375941B (Direct)
AU (1) AU528013B2 (Direct)
BE (1) BE883204A (Direct)
CH (1) CH646170A5 (Direct)
CS (1) CS241026B2 (Direct)
DD (1) DD150897A5 (Direct)
DE (1) DE3019019A1 (Direct)
ES (1) ES491608A0 (Direct)
FR (1) FR2456744A1 (Direct)
GB (1) GB2051054B (Direct)
GR (1) GR68462B (Direct)
HU (1) HU178523B (Direct)
IT (1) IT1149882B (Direct)
NL (1) NL8002853A (Direct)
SU (3) SU978731A3 (Direct)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469868A (en) * 1982-05-24 1984-09-04 Warner-Lambert Company Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines
DE3942357A1 (de) * 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh 3-aminopyrazolo-heterocyclen, deren verwendung zur bestimmung von wasserstoffperoxid, wasserstoffperoxid-bildenden systemen, peroxidase, peroxidatisch wirksamen substanzen oder von elektronenreichen aromatischen verbindungen, entsprechende bestimmungsverfahren und hierfuer geeignete mittel
JP2002537397A (ja) * 1999-02-22 2002-11-05 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 抗炎症剤としての多環ヘテロ環式誘導体
GB2454549B (en) * 2007-09-25 2009-09-23 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect
CN103130810B (zh) * 2013-03-11 2015-02-25 河南师范大学 一种吡唑并[1,5-c]喹唑啉类化合物的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313815A (en) * 1964-05-04 1967-04-11 Sterling Drug Inc 8-chloropyrazolo-[1, 5-c]quinazoline derivatives and methods of preparing same
US3531482A (en) * 1966-10-13 1970-09-29 Sandoz Ag Pyrazolo(1,5-c)quinazolines
US3897434A (en) * 1974-04-12 1975-07-29 Lilly Co Eli Pyrazolo{8 1,5-c{9 quinazolin-5(6H)-ones
US4076818A (en) * 1976-07-02 1978-02-28 E. R. Squibb & Sons, Inc. Pyrazolo [1,5-C]quinazoline derivatives and related compounds
US4110452A (en) * 1977-10-17 1978-08-29 E. R. Squibb & Sons, Inc. Pyrazolo (1,5-c) quinazoline derivatives and related compounds
US4112098A (en) * 1977-10-17 1978-09-05 E. R. Squibb & Sons, Inc. Pyrazolo[1,5-c]quinazoline derivatives and related compounds
US4198412A (en) * 1978-12-13 1980-04-15 E. R. Squibb & Sons, Inc. Pyrazolo [1,5-C] quinazoline derivatives and their use in treating allergic conditions

Also Published As

Publication number Publication date
CH646170A5 (de) 1984-11-15
HU178523B (en) 1982-05-28
DE3019019A1 (de) 1980-11-27
IT1149882B (it) 1986-12-10
US4303660A (en) 1981-12-01
GB2051054A (en) 1981-01-14
AU528013B2 (en) 1983-03-31
SU1015828A3 (ru) 1983-04-30
ES8105319A1 (es) 1981-05-16
CS241026B2 (en) 1986-03-13
DE3019019C2 (Direct) 1988-12-01
SU978731A3 (ru) 1982-11-30
GR68462B (Direct) 1981-12-30
CS340780A2 (en) 1985-06-13
ATA262580A (de) 1984-02-15
BE883204A (fr) 1980-11-10
JPS55154974A (en) 1980-12-02
NL8002853A (nl) 1980-11-20
JPH0227356B2 (Direct) 1990-06-15
AT375941B (de) 1984-09-25
FR2456744A1 (fr) 1980-12-12
AU5848580A (en) 1980-11-20
IT8022111A0 (it) 1980-05-16
DD150897A5 (de) 1981-09-23
GB2051054B (en) 1983-05-18
SU1017171A3 (ru) 1983-05-07
ES491608A0 (es) 1981-05-16

Similar Documents

Publication Publication Date Title
FR2463877B1 (Direct)
FR2460278B1 (Direct)
FR2447964B1 (Direct)
FR2448031B1 (Direct)
FR2447325B1 (Direct)
FR2448541B1 (Direct)
FR2447915B1 (Direct)
DE3049961A1 (Direct)
FR2446086B1 (Direct)
FR2449618B1 (Direct)
FR2446390B1 (Direct)
GR68462B (Direct)
JPS55141661U (Direct)
FR2449516B1 (Direct)
FR2446551B1 (Direct)
FR2446037B3 (Direct)
JPS55138440U (Direct)
JPS55121414U (Direct)
JPS55130708U (Direct)
JPS55137532U (Direct)
JPS55115490U (Direct)
FR2450389B1 (Direct)
FR2448264B1 (Direct)
FR2447227B1 (Direct)
JPS5435609Y1 (Direct)

Legal Events

Date Code Title Description
ST Notification of lapse